rac-nor laudanosine
CAS: 13074-31-2
Ref. 3D-FR27650
| 1kg | Descatalogado | ||
| 2kg | Descatalogado | ||
| 5kg | Descatalogado | ||
| 10kg | Descatalogado | ||
| 500g | Descatalogado |
Información del producto
Nombre:
rac-nor laudanosine
Sinónimos:
- 1-[(3,4-Dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxyisoquinoline1,2,3,4-Tetrahydro-6,7-dimethoxy-1-veratrylisoquinoline (±)-N-Norlaudanosine
- (+/-)-Tetrahydropapaverine
- (±)-N-Norlaudanosine
- (±)-Norlaudanosine
- 1,2,3,4-Tetrahydropapaverine
- 1-(3,4-Dimethoxybenzyl)-6,7-Dimethoxy-1,2,3,4-Tetrahydroisoquinoline
- 1-(3,4-Dimethoxybenzyl)-6,7-Dimethoxy-1,2,3,4-Tetrahydroisoquinolinium Chloride
- 1-[(3,4-Dimethoxyphenyl)Methyl]-1,2,3,4-Tetrahydro-6,7-Dimethoxyisoquinoline
- Isoquinoline, 1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratryl-
- Isoquinoline, 1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-
- Ver más sinónimos
Descripción:
Rac-nor laudanosine is a potent dopamine receptor agonist that is used for the treatment of Parkinson's disease. It has been shown to inhibit cell growth in culture and reduce acid formation, which may be due to its ability to inhibit cyclic nucleotide phosphodiesterases. Rac-nor laudanosine also inhibits the production of dopamine from tyrosine by inhibiting the conversion of dopamine into dihydroxyphenylalanine via the enzyme tyrosine hydroxylase. The asymmetric synthesis of rac-nor laudanosine allows it to have a high yield with less reaction time and fewer steps. This drug was shown to bind in vitro to human receptors.
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
343.42 g/mol
Fórmula:
C20H25NO4
Pureza:
Min. 95%
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
